Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Cell therapy in Parkinson's disease – stop or go?

Abstract

The results of the first double-blind placebo-controlled trial using grafts of embryonic tissue to treat Parkinson's disease have aroused widespread interest and debate about the future of cell replacement therapies. What are the key issues that need to be resolved and the directions in which this technology is likely to develop?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Freed, C. R. et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710– 719 (2001).

    Article  CAS  Google Scholar 

  2. Kolata, G. Parkinson's disease is set back by failure of fetal cell implants. NY Times 8 March, 381 (2001).

  3. Editorial. Prospects for Parkinson's disease. Nature Med. 7, 381 (2001).

  4. Olson, L. & Malmfors, T. Growth characteristics of adrenergic nerves in the adult rat. Fluorescence histochemical and 3H-noradrenaline uptake studies using tissue transplantation to the anterior chamber of the eye. Acta Physiol. Scand. 348, S1– S112 (1970).

    Google Scholar 

  5. Olson, L. & Seiger, Å. Brain tissue transplanted to the anterior chamber of the eye. I. Fluorescence histochemistry of immature catecholamine and 5-hydroxytryptamine neurons innervating the iris. Z. Zellforsch. 195, 175–194 (1972).

    Article  Google Scholar 

  6. Olson, L., Seiger, Å. & Strömberg, I. Intraocular transplantation in rodents: a detailed account of the procedure and examples of its use in neurobiology with special reference to brain tissue grafting. Adv. Cell. Neurobiol. 4, 407–442 ( 1983).

    Google Scholar 

  7. Stenevi, U., Björklund, A. & Svendgaard, N.-A. Transplantation of central and peripheral monoamine neurons to the adult rat brain: techniques and conditions for survival. Brain Res. 114, 1–20 ( 1976).

    Article  CAS  Google Scholar 

  8. Björklund, A., Schmidt, R. H. & Stenevi, U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res. 212, 39–45 (1980).

    Article  Google Scholar 

  9. Perlow, M. J. et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204, 643–647 (1979).

    Article  CAS  Google Scholar 

  10. Björklund, A. & Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral transplants. Brain Res. 177, 555–560 (1979).

    Article  Google Scholar 

  11. Björklund, A., Dunnett, S. B., Stenevi, U., Lewis, M. E. & Iversen, S. D. Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199, 307–333 (1980).

    Article  Google Scholar 

  12. Dunnett, S. B., Björklund, A., Schmidt, R. H., Stenevi, U. & Iversen, S. D. Intracerebral grafting of neuronal cell suspensions. V. Behavioral recovery in rats with bilateral 6-OHDA lesions following implantation of nigral cell suspensions. Acta Physiol. Scand. 522, S39–S47 ( 1983).

    Google Scholar 

  13. Schmidt, R. H., Björklund, A., Stenevi, U., Dunnett, S. B. & Gage, F. H. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. 522, S19–S28 (1983).

    Google Scholar 

  14. Sauer, H. & Brundin, P. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Rest. Neurol. Neurosci. 2, 123–135 (1991).

    CAS  Google Scholar 

  15. Nikkhah, G. et al. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: A detailed account of the methodology. Neuroscience 63, 57–72 ( 1994).

    Article  CAS  Google Scholar 

  16. Brundin, P. et al. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 9, 179–195 (2000).

    Article  CAS  Google Scholar 

  17. Winkler, C., Kirik, D., Björklund, A. & Dunnett, S. B. Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Prog. Brain Res. 127, 233 –265 (2000).

    Article  CAS  Google Scholar 

  18. Taylor, J. R. et al. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Exp. Brain Res. 85, 335– 348 (1991).

    Article  CAS  Google Scholar 

  19. Annett, L. E., Torres, E. M., Ridley, R. M., Baker, H. F. & Dunnett, S. B. A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions. Exp. Brain Res. 103, 355–371 (1995).

    Article  CAS  Google Scholar 

  20. Dunnett, S. B. & Björklund, A. in Functional Neural Transplantation (eds Dunnett, S. B. & Björklund, P.) 531–567 (Raven, New York, 1994).

    Google Scholar 

  21. Backlund, E. O. et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. J. Neurosurg. 62, 169– 173 (1985).

    Article  CAS  Google Scholar 

  22. Madrazo, I. et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 316, 831–834 (1987).

    Article  CAS  Google Scholar 

  23. Quinn, N. P. The clinical application of cell grafting techniques in patients with Parkinson's disease. Prog. Brain Res. 82, 619– 625 (1990).

    Article  CAS  Google Scholar 

  24. Boer, G. J. Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. J. Neurol. 242, 1–13 (1994).

    Article  CAS  Google Scholar 

  25. Madrazo, I. et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N. Engl. J. Med. 318, 51 (1988 ).

    CAS  PubMed  Google Scholar 

  26. Lindvall, O. et al. Human fetal dopamine neurons grafted into the striatum in 2 patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46, 615–631 (1989).

    Article  CAS  Google Scholar 

  27. Langston, J. W., Widner, H. & Goetz, C. G. Core assessment program for intracerebral transplantation (CAPIT). Mov. Disord. 7, 2– 13 (1992).

    Article  CAS  Google Scholar 

  28. Defer, G. L., Widner, H., Marié, R. M., Rémy, P. & Levivier, M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD) . Mov. Disord. 14, 572– 584 (1999).

    Article  CAS  Google Scholar 

  29. Lindvall, O. & Hagell, P. Clinical observations after neural transplantation in Parkinson's disease. Prog. Brain Res. 127, 299–320 (2000).

    Article  CAS  Google Scholar 

  30. Lindvall, O. et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247, 574–577 (1990).

    Article  CAS  Google Scholar 

  31. Lindvall, O. et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35, 172–180 (1994).

    Article  CAS  Google Scholar 

  32. Wenning, G. K. et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42, 95–107 (1997).

    Article  CAS  Google Scholar 

  33. Hagell, P. et al. Sequential bilateral transplantation in Parkinson's disease — effects of the second graft. Brain 122, 1121–1132 (1999).

    Article  Google Scholar 

  34. Brundin, P. et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123, 1380–1390 (2000).

    Article  Google Scholar 

  35. Widner, H. et al. Bilateral fetal mesencephalic grafting in 2 patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) . N. Engl. J. Med. 327, 1556– 1563 (1992).

    Article  CAS  Google Scholar 

  36. Sawle, G. V. et al. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [F-18] 6-l-fluorodopa studies in 2 patients with putaminal implants . Ann. Neurol. 31, 166– 173 (1992).

    Article  CAS  Google Scholar 

  37. Piccini, P. et al. Dopamine release from nigral transplants visualised in vivo in a Parkinson's patient. Nature Neurosci. 2, 1137–1140 (1999).

    Article  CAS  Google Scholar 

  38. Brundin, P. in Neural Transplantation: A Practical Approach Transplantation (eds Dunnett, S. B. & Björklund, P.) 139–160 (IRL, Oxford, 1992).

    Google Scholar 

  39. Freeman, T. B. et al. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N. Engl. J. Med. 341 , 988–992 (1999).

    Article  CAS  Google Scholar 

  40. Macklin, R. Placebo surgery in trials of therapy for Parkinson's disease. Reply. N. Engl. J. Med. 342, 355 ( 2000).

    Article  Google Scholar 

  41. Widner, H. et al. NIH neural transplantation funding. Science 263, 737 (1994).

    Article  CAS  Google Scholar 

  42. Kordower, J. H. et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118–1124 (1995).

    Article  CAS  Google Scholar 

  43. Lee, C. S., Cenci, M. A., Schulzer, M. & Björklund, A. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain 123, 1365–1379 (2000).

    Article  Google Scholar 

  44. Dunnett, S. B. & Björklund, A. Parkinson's disease: prospects for novel restorative and neuroprotective treatments. Nature 399, S32–S39 ( 1999).

    Article  Google Scholar 

  45. Dunnett, S. B. et al. in Neurochemistry Transplantation (eds Teelken, A. W. & Korf, J.) 249–257 (Plenum, New York, 1997).

  46. Deacon, T. et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Med. 3, 350–353 ( 1997).

    Article  CAS  Google Scholar 

  47. Schumacher, J. M. et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54, 1042– 1050 (2000).

    Article  CAS  Google Scholar 

  48. Piccini, P. et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann. Neurol. 48, 689–695 ( 2000).

    Article  CAS  Google Scholar 

  49. Hauser, R. A. et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56, 179–187 (1999).

    Article  CAS  Google Scholar 

  50. Nguyen, J. P. et al. Bilateral intrastriatal grafts of fetal mesencephalic neurons in Parkinson's disease: long-term results in 9 patients. Mov. Disord. 15, S53–S54 ( 2000).

    Article  Google Scholar 

  51. Mendez, I. et al. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease — report of two cases and technical considerations. J. Neurosurg. 92, 863–869 (2000).

    Article  CAS  Google Scholar 

  52. Defer, G. L. et al. Long-term outcome of unilaterally transplanted Parkinsonian patients. 1. Clinical approach. Brain 119, 41–50 (1996).

    Article  Google Scholar 

  53. Rémy, P. et al. Clinical correlates of [18F]fluorodopa uptake in five grafted Parkinsonian patients. Ann. Neurol. 38, 580–588 (1995).

    Article  Google Scholar 

  54. Dunnett, S. B., Björklund, A., Stenevi, U. & Iversen, S. D. Behavioral recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. 2. Bilateral lesions . Brain Res. 229, 457–470 (1981).

    Article  CAS  Google Scholar 

  55. Dunnett, S. B., Björklund, A., Stenevi, U. & Iversen, S. D. Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 229, 209–217 (1981).

    Article  CAS  Google Scholar 

  56. Dunnett, S. B., Björklund, A., Stenevi, U. & Iversen, S. D. Behavioral recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. 1. Unilateral lesions . Brain Res. 215, 147–161 (1981).

    Article  CAS  Google Scholar 

  57. Lindvall, O. et al. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease . Lancet 2, 1483–1484 (1988).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Related links

Related links

FURTHER INFORMATION

Virtual hospital: functional anatomy of the basal ganglia

ENCYCLOPEDIA OF LIFE SCIENCES

Parkinson disease

MIT ENCYCLOPEDIA OF COGNITIVE SCIENCE

Basal ganglia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunnett, S., Björklund, A. & Lindvall, O. Cell therapy in Parkinson's disease – stop or go?. Nat Rev Neurosci 2, 365–369 (2001). https://doi.org/10.1038/35072572

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/35072572

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing